Gufic Biosciences Share Price
443.90+4.55 (+1.04%)
+22.39% past 1 Year
Gufic Biosciences Limited is a public company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised
Corporate filings & documents
Announcements
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Promotion and Change in Designation of Senior Management Personnel is attached herewith
1 day agoIntimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Promotion and Change in Designation of Senior Management Personnel is attached herewith
1 day agoWritten Transcript of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
1 week agoWritten Transcript of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
1 week agoNewspaper advertisement regarding Special Window for re-lodgement of transfer and dematerialization of physical shares is attached herewith
2 weeks agoNewspaper advertisement regarding Special Window for re-lodgement of transfer and dematerialization of physical shares is attached herewith
2 weeks agoIntimation of Audio Recording of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
2 weeks agoIntimation of Audio Recording of Earnings Conference Call held on August 17 2026 at 04:30 p.m. is attached herewith
2 weeks agoNewspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 is attached herewith.
2 weeks agoNewspaper Advertisement of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended June 30 2026 is attached herewith.
2 weeks agoInvestor Presentation for the Quarter ended June 30 2026 is attached herewith
2 weeks agoInvestor Presentation for the Quarter ended June 30 2026 is attached herewith
2 weeks agoApproval for Incorporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.
2 weeks agoApproval for Incorporation of Subsidiary in the Philippines and Investment by way of Subscription to its Equity Share Capital is attached herewith.
2 weeks agoUnaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2026 is attached herewith.
2 weeks agoUnaudited Financial Results (Standalone and Consolidated) for the Quarter ended June 30 2026 is attached herewith.
2 weeks agoOutcome of the Board of Directors Meeting held on Friday August 14 2026 is attached herewith.
2 weeks agoOutcome of the Board of Directors Meeting held on Friday August 14 2026 is attached herewith.
2 weeks agoNewspaper Advertisement - Notice of 42nd Annual General Meeting of the Company and evoting details is attached herewith.
3 weeks agoNewspaper Advertisement - Notice of 42nd Annual General Meeting of the Company and evoting details is attached herewith.
3 weeks agoBusiness Responsibility and Sustainability Report for the Financial Year ended March 31 2026 is attached herewith
3 weeks agoBusiness Responsibility and Sustainability Report for the Financial Year ended March 31 2026 is attached herewith
3 weeks agoAnnual Report for the Financial Year 2025-2026 alongwith Notice of 42nd Annual General Meeting is attached herewith.
3 weeks agoAnnual Report for the Financial Year 2025-2026 alongwith Notice of 42nd Annual General Meeting is attached herewith.
3 weeks agoIntimation for book closure and record date for the purpose of 42nd Annual General Meeting and payment of final dividend for the financial year ended March 31 2026
3 weeks agoIntimation for book closure and record date for the purpose of 42nd Annual General Meeting and payment of final dividend for the financial year ended March 31 2026
3 weeks agoIntimation of 42nd Annual General Meeting is attached herewith
3 weeks agoIntimation of 42nd Annual General Meeting is attached herewith
3 weeks agoIntimation of Earnings Conference Call scheduled to be held on August 17 2026 is attached herewith
3 weeks agoIntimation of Earnings Conference Call scheduled to be held on August 17 2026 is attached herewith
3 weeks agoGufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026
3 weeks agoGufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 inter alia to consider and approve Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30 2026
3 weeks agoNewspaper Advertisement - Notice of the 42nd Annual General Meeting of the Company is attached herewith
3 weeks agoNewspaper Advertisement - Notice of the 42nd Annual General Meeting of the Company is attached herewith
3 weeks agoIntimation for Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company is attached herewith.
1 month agoIntimation for Re-appointment of Mr. Pankaj Jayakumar Gandhi (DIN: 00001858) as the Whole Time Director of the Company is attached herewith.
1 month agoOutcome of the Board of Directors Meeting held on Friday July 31 2026 is attached herewith
1 month agoOutcome of the Board of Directors Meeting held on Friday July 31 2026 is attached herewith
1 month agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 is attached herewith
1 month agoCertificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended June 30 2026 is attached herewith
1 month agoNewspaper Advertisement regarding Notice for transfer of equity shares to Investor Education and Protection Fund (IEPF) Authority is attached herewith
1 month agoNewspaper Advertisement regarding Notice for transfer of equity shares to Investor Education and Protection Fund (IEPF) Authority is attached herewith
1 month agoIntimation of closure of Trading Window for the quarter ended June 30 2026 is attached herewith
2 months agoIntimation of closure of Trading Window for the quarter ended June 30 2026 is attached herewith
2 months agoNewspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares is attached herewith.
2 months agoNewspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares is attached herewith.
2 months agoWritten Transcript of Earnings Conference Call held on June 01 2026 at 04:30 PM is attached herewith.
3 months agoWritten Transcript of Earnings Conference Call held on June 01 2026 at 04:30 PM is attached herewith.
3 months agoCorrigendum and Clarification to Intimation dated May 29 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith
3 months agoCorrigendum and Collaboration to Intimation dated May 29 2026 regarding Subscription to Shares of Saraswat Co-operative Bank Limited is attached herewith
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
Jun 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Jun 2021
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-08-28
Dividend
0.1
2025-09-22
Dividend
0.1
2024-09-17
Dividend
0.1
2023-09-21
Dividend
0.1
2022-08-24
Dividend
0.1
2021-09-09
Dividend
0.1
2020-11-03
Dividend
0.05
2019-09-20
Dividend
0.05
2018-09-19
Dividend
0.05
2017-08-28
Dividend
0.05
2016-09-19
Dividend
0.05
2015-09-22
Dividend
0.05
2014-09-18
Dividend
0.05
2013-09-19
Dividend
0.05
2012-08-16
Dividend
0.05
2011-09-16
Dividend
0.05
2010-09-20
Dividend
0.05
Company details
Registered office
Shop - 37, First Floor, Kamala Bhavan I I Swami Nityanand Road Andheri (East) Mumbai Maharashtra PIN: 400069 Tel No: NULL Fax No: NULL Email: [email protected] Internet: www.guficbio.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Ami Shah, Company Secretary & Compliance Officer
Jayesh P Choksi, Chairman & Managing Director
Jayesh P Choksi, Chairman & Managing Director
Pranav J Choksi, Whole Time Director & Chief Executive Officer
Pankaj J Gandhi, Whole Time Director
Anu S Aurora, Non Executive Independent Director
Akshya Kumar Mahapatra, Non Executive Independent Director
Kamal Kishore Seth, Non Executive Independent Director
Details
BSE 509079
NSE GUFICBIO
ISIN INE742B01025